- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Treats Adults
Mehdi S Mirsaeidi, MD, MPH
Pulmonologist, Critical Care Medicine Physician
Mehdi S Mirsaeidi, MD, MPH
- Additional languages:
- Persian
Request appointment online
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 30 Years - NA Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
My publications
Filter publications
241 publications
2016
Haarlem 3 is the predominant genotype family in multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in the capital of Iran: A 5-year survey.
Journal of global antimicrobial resistance
鈥�2016
The Association between ESR and CRP and Systemic Hypertension in Sarcoidosis.
International journal of hypertension
鈥�2016
The simultaneous recording of right- and left-sided electrocardiogram in acute pulmonary embolism.
The American journal of emergency medicine
鈥�2016
Annexins family: insights into their functions and potential role in pathogenesis of sarcoidosis.
Journal of translational medicine
鈥�2016
High prevalence of Mycobacterium tuberculosis mixed infection in the capital of moderate tuberculosis incidence country.
Microbial pathogenesis
鈥�